FI105389B - Menetelmä levosimendaaniannon siedettävyyden seuraamiseksi - Google Patents

Menetelmä levosimendaaniannon siedettävyyden seuraamiseksi Download PDF

Info

Publication number
FI105389B
FI105389B FI980903A FI980903A FI105389B FI 105389 B FI105389 B FI 105389B FI 980903 A FI980903 A FI 980903A FI 980903 A FI980903 A FI 980903A FI 105389 B FI105389 B FI 105389B
Authority
FI
Finland
Prior art keywords
levosimendan
metabolite
administration
plasma
monitoring
Prior art date
Application number
FI980903A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI980903A (fi
FI980903A0 (fi
Inventor
Lasse Lehtonen
Timo Lotta
Pekka Ottoila
Aira Heikkilae
Hanna Nikkanen
Original Assignee
Orion Yhtymae Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oyj filed Critical Orion Yhtymae Oyj
Priority to FI980903A priority Critical patent/FI105389B/fi
Publication of FI980903A0 publication Critical patent/FI980903A0/fi
Priority to PCT/FI1999/000330 priority patent/WO1999056134A1/fr
Priority to AU35247/99A priority patent/AU3524799A/en
Publication of FI980903A publication Critical patent/FI980903A/fi
Application granted granted Critical
Publication of FI105389B publication Critical patent/FI105389B/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9453—Cardioregulators, e.g. antihypotensives, antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI980903A 1998-04-23 1998-04-23 Menetelmä levosimendaaniannon siedettävyyden seuraamiseksi FI105389B (fi)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI980903A FI105389B (fi) 1998-04-23 1998-04-23 Menetelmä levosimendaaniannon siedettävyyden seuraamiseksi
PCT/FI1999/000330 WO1999056134A1 (fr) 1998-04-23 1999-04-23 Procede pour surveiller la tolerance a l'administration de levosimendane
AU35247/99A AU3524799A (en) 1998-04-23 1999-04-23 A method for monitoring the tolerability of levosimendan administration

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980903 1998-04-23
FI980903A FI105389B (fi) 1998-04-23 1998-04-23 Menetelmä levosimendaaniannon siedettävyyden seuraamiseksi

Publications (3)

Publication Number Publication Date
FI980903A0 FI980903A0 (fi) 1998-04-23
FI980903A FI980903A (fi) 1999-10-24
FI105389B true FI105389B (fi) 2000-08-15

Family

ID=8551577

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980903A FI105389B (fi) 1998-04-23 1998-04-23 Menetelmä levosimendaaniannon siedettävyyden seuraamiseksi

Country Status (3)

Country Link
AU (1) AU3524799A (fr)
FI (1) FI105389B (fr)
WO (1) WO1999056134A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
AU3524799A (en) 1999-11-16
FI980903A (fi) 1999-10-24
WO1999056134A1 (fr) 1999-11-04
FI980903A0 (fi) 1998-04-23

Similar Documents

Publication Publication Date Title
US4708952A (en) Method of treatment of the infectious and viral diseases by one time interference
US4840966A (en) Method of treating hypertension
Udilova et al. The antioxidant activity of caroverine
Cheymol et al. Pharmacokinetics of β‐adrenoceptor blockers in obese and normal volunteers
KR101236227B1 (ko) 에스리카르바제핀 아세테이트 및 그의 사용방법
Benkusky et al. Peroxynitrite-mediated attenuation of α-and β-adrenoceptor agonist-induced vascular responses in vivo
Bräutigam et al. Determination of celecoxib in human plasma and rat microdialysis samples by liquid chromatography tandem mass spectrometry
Zekorn et al. Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidation
Klotz et al. Effect of single doses of cimetidine and ranitidine on the steady‐state plasma levels of midazolam
FI105389B (fi) Menetelmä levosimendaaniannon siedettävyyden seuraamiseksi
Martens et al. Clinical experience with the benzodiazepine antagonist flumazenil in suspected benzodiazepine or ethanol poisoning
Hiroshi et al. Effects of heterocyclic amines in food on dopamine metabolism in nigro-striatal dopaminergic neurons
Tarbah et al. Kinetics of kavain and its metabolites after oral application
IL134263A (en) Pharmacological preparations containing pancoquinone for the treatment of Alzheimer's disease
McElnay et al. The effect of pH on the buccal and sublingual absorption of captopril
Ndanusa et al. The effect of single dose of rifampicin on the pharmacokinetics of oral nifedipine
Magnussen et al. Plasma Accumulation and Metabolism of Orally Administered Single Dose L‐5‐Hydroxytryptophan in Man
Tunnicliff et al. Influence of repeated treatment with buspirone on central 5-hydroxytryptamine and dopamine synthesis
NZ237519A (en) Ipriflavone in an oily carrier
KR100960597B1 (ko) 레보시멘단의 조절 방출성 경구 조성물
Kroboth et al. Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokinetics.
Park et al. Quantification of isradipine in human plasma using LC–MS/MS for pharmacokinetic and bioequivalence study
Klarskov et al. Structural characterization of a case-implicated contaminant," Peak X," in commercial preparations of 5-hydroxytryptophan.
JP2000319177A (ja) ストレス改善剤
Izurieta-Sánchez et al. Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats

Legal Events

Date Code Title Description
MA Patent expired